These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31157898)

  • 1. Comparative efficacy and acceptability of treatments for restless legs syndrome in end-stage renal disease: a systematic review and network meta-analysis.
    Huang CW; Lee MJ; Wang LJ; Lee PT; Tu YK; Hsu CW; Lin PY
    Nephrol Dial Transplant; 2020 Sep; 35(9):1609-1618. PubMed ID: 31157898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions for chronic kidney disease-associated restless legs syndrome.
    Gopaluni S; Sherif M; Ahmadouk NA
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD010690. PubMed ID: 27819409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What treatment works best for restless legs syndrome? Meta-analyses of dopaminergic and non-dopaminergic medications.
    Hornyak M; Scholz H; Kohnen R; Bengel J; Kassubek J; Trenkwalder C
    Sleep Med Rev; 2014 Apr; 18(2):153-64. PubMed ID: 23746768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rotigotine in Hemodialysis-Associated Restless Legs Syndrome: A Randomized Controlled Trial.
    Dauvilliers Y; Benes H; Partinen M; Rauta V; Rifkin D; Dohin E; Goldammer N; Schollmayer E; Schröder H; Winkelman JW
    Am J Kidney Dis; 2016 Sep; 68(3):434-43. PubMed ID: 26851201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological and non-pharmacological treatments for restless legs syndrome in end-stage kidney disease: a systematic review and component network meta-analysis.
    Chen JJ; Lee TH; Tu YK; Kuo G; Yang HY; Yen CL; Fan PC; Chang CH
    Nephrol Dial Transplant; 2022 Sep; 37(10):1982-1992. PubMed ID: 34612498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine agonists for restless legs syndrome.
    Scholz H; Trenkwalder C; Kohnen R; Riemann D; Kriston L; Hornyak M
    Cochrane Database Syst Rev; 2011 Mar; 2011(3):CD006009. PubMed ID: 21412893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of non-ergot dopamine agonists on health-related quality of life of patients with restless legs syndrome.
    Talati R; Phung OJ; Mather J; Coleman CI
    Ann Pharmacother; 2009 May; 43(5):813-21. PubMed ID: 19401472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A network meta-analysis of the effectiveness and safety of drugs for restless legs syndrome in dialysis patients.
    Tang M; Ge J; Sun KX; Cui B; Guan Y; Wang JW
    Semin Dial; 2022 Jul; 35(4):293-306. PubMed ID: 34585446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic therapy for primary restless legs syndrome: a systematic review and meta-analysis.
    Wilt TJ; MacDonald R; Ouellette J; Khawaja IS; Rutks I; Butler M; Fink HA
    JAMA Intern Med; 2013 Apr; 173(7):496-505. PubMed ID: 23460396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Pramipexole for the Treatment of Primary Restless Leg Syndrome: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
    Liu GJ; Wu L; Lin Wang S; Xu LL; Ying Chang L; Fu Wang Y
    Clin Ther; 2016 Jan; 38(1):162-179.e6. PubMed ID: 26572941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gabapentin versus levodopa for the treatment of Restless Legs Syndrome in hemodialysis patients: an open-label study.
    Micozkadioglu H; Ozdemir FN; Kut A; Sezer S; Saatci U; Haberal M
    Ren Fail; 2004 Jul; 26(4):393-7. PubMed ID: 15462107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies.
    Fulda S; Wetter TC
    Brain; 2008 Apr; 131(Pt 4):902-17. PubMed ID: 17932100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized trials of dopamine agonists in restless legs syndrome: a systematic review, quality assessment, and meta-analysis.
    Zintzaras E; Kitsios GD; Papathanasiou AA; Konitsiotis S; Miligkos M; Rodopoulou P; Hadjigeorgiou GM
    Clin Ther; 2010 Feb; 32(2):221-37. PubMed ID: 20206780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From bench to bedside: An overview of rotigotine for the treatment of restless legs syndrome.
    Bogan RK
    Clin Ther; 2014 Mar; 36(3):436-55. PubMed ID: 24636821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gabapentin enacarbil, pregabalin and rotigotine are equally effective in restless legs syndrome: a comparative meta-analysis.
    Iftikhar IH; Alghothani L; Trotti LM
    Eur J Neurol; 2017 Dec; 24(12):1446-1456. PubMed ID: 28888061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Gabapentin Enacarbil on Individual Items of the International Restless Legs Study Group Rating Scale and Post-sleep Questionnaire in Adults with Moderate-to-Severe Primary Restless Legs Syndrome: Pooled Analysis of 3 Randomized Trials.
    Ahmed M; Hays R; Steven Poceta J; Jaros MJ; Kim R; Shang G
    Clin Ther; 2016 Jul; 38(7):1726-1737.e1. PubMed ID: 27288210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical management of restless legs syndrome in end-stage renal disease patients.
    Sahli ZT; Jo J; Mousa SA; Tarazi FI
    CNS Spectr; 2017 Feb; 22(1):14-21. PubMed ID: 27702420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron for restless legs syndrome.
    Trotti LM; Bhadriraju S; Becker LA
    Cochrane Database Syst Rev; 2012 May; 5(5):CD007834. PubMed ID: 22592724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome.
    Sloand JA; Shelly MA; Feigin A; Bernstein P; Monk RD
    Am J Kidney Dis; 2004 Apr; 43(4):663-70. PubMed ID: 15042543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.